Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 11-20 of 78

Page
per page
  1. Huwentoxin XVI
    B7789 Huwentoxin XVI
    Summary: N-type Ca2+ channel blocker,potent and selective
      Soluble to 1 mg/mL
  2. Barnidipine (hydrochloride)
    C3727 Barnidipine (hydrochloride)
    Summary: calcium-channel blocker
      insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL
  3. Methsuximide
    C4851 Methsuximide
    Summary: anticonvulsant medication
  4. Fluspirilene
    C5110 Fluspirilene
    Summary: potent, non-competitive antagonist of agonist-activated L-type calcium channels
      ≤0.3 mg/mL
  5. Dehydroepiandrosterone (DHEA)
    B1375 Dehydroepiandrosterone (DHEA)
    Summary: Endogenous steroid hormone
      insoluble in H2O; ≥13.7 mg/mL
  6. Nisoldipine
    B1989 Nisoldipine
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: calcium channel blocker
  7. Manidipine 2HCl
    B1419 Manidipine 2HCl
    Summary: Calcium channel blocker
      insoluble in H2O; ≥69 mg/mL
  8. Clevidipine Butyrate
    B1415 Clevidipine Butyrate
    Summary: Dihydropyridine calcium channel blocker
      ≥21.4 mg/mL
  9. Gabapentin HCl
    B1529 Gabapentin HCl
    Summary: GABA analog
  10. Verapamil HCl
    B1867 Verapamil HCl
     1 Citation
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: L-type calcium channel blocker
      ≥14.45 mg/mL

Items 11-20 of 78

Page
per page